Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia

Leukemia. 2001 Dec;15(12):1999-2002. doi: 10.1038/sj.leu.2402297.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cytarabine / administration & dosage*
  • Cytarabine / therapeutic use
  • Cytarabine / toxicity
  • Dose-Response Relationship, Drug
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Treatment Outcome

Substances

  • Cytarabine